Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2015

May 20, 2015

30643_dirs_2015-05-20_4a1bc760-95d8-4c36-9f02-2a6e02067823.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2015-05-18

Reporting Person: Margolis Robert J (Director, Co-Chairman of the Board)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-05-18 Common Stock S 15700 $82.2445 Disposed 2370028 Indirect
2015-05-19 Common Stock S 15700 $83.2223 Disposed 2354328 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 130000 Indirect
Common Stock 292 Direct

Footnotes

F1: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 18, 2014.

F2: Represents the weighted average sale price of $82.2445. The range of prices for the sale of these shares was $81.40 - $82.88, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F3: Represents the weighted average sale price of $83.2223. The range of prices for the sale of these shares was $82.70 - $83.46, rounded to the nearest hundredths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F4: Robert and Lisa Margolis Family Trust, 7/27/2000.

F5: Margolis Family GST Exempt Trust, 12/11/2012.